AMBOSS

AMBOSS

Private
Berlin, BerlinHealthcare & Life Sciencesamboss.com

Last Round

Early Funding

Mar 25, 2025

Total Funding Raised

$299.3M

Company Overview

Amboss is a healthcare education company that offers a comprehensive learning application providing medical students with access to detailed information on diseases, visual resources, and a database of clinics to support their studies and professional development.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Digital Publishing

Business Model

B2C

Customer Profile

Subscription SaaS, Freemium

AI Layer

Application

Keywords

medical knowledge platformmedical exam prepquestion bankQbankclinical companionUSMLE preppoint of care referencemedical educationclinical decision supportmedtechmedical librarymedical appNBME prephealth techAnki integrationdrug dosing referenceAI for medical education

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AMBOSS Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AMBOSS Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingMar 25, 2025
Series BSep 30, 2019

Key People

Founding team and executive leadership

Madjid Salimi

Co-Founder Co-CEO

Founding Team

AMBOSS Investors

Notable investors and investment history

InvestorRounds
PartechSeries B
PartechEarly Funding, Series B
LGT Private BankingEarly Funding
Target GlobalSeries B
M&G InvestmentsEarly Funding
Partech PartnersSeries B
Project A VenturesEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Platform now used by over 1 million medical professionals globally.

  • Apr 21, 2026

    AI Mode offers structured, evidence-based explanations for medical questions.

AMBOSS Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AMBOSS Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AMBOSS's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerlin, Berlin
Employee Range1,026
Year Founded2012
Last FundingMar 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.